LAG3 and neoplasm: The percentages of LAG-3+ sTILs, LAG-3 + iTILs, PD-L1+ immune cells (IC) and PD-L1+ tumor cells (TC) were 55.1%, 40.8%, 69.4% and 14.3%, respectively.